Buyout Chatter Lifts TG Therapeutics Shares — But No Deal Confirmed

Unconfirmed buyout speculation tied to Betaville surrounds TG Therapeutics, maker of BRIUMVI for multiple sclerosis. No official deal talks disclosed.